Search

Your search keyword '"Lambrechts, Sandrina"' showing total 431 results

Search Constraints

Start Over You searched for: Author "Lambrechts, Sandrina" Remove constraint Author: "Lambrechts, Sandrina"
431 results on '"Lambrechts, Sandrina"'

Search Results

101. HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

102. HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

103. ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

104. Expression III: Final results of an international survey in eight European countries with 1,830 patients—What are the differences in expectations from their doctors and therapy management of patients with primary and recurrent ovarian cancer? (NOGGO/ENGOT-ov4 study).

105. Genomic alterations in paired pretreatment (pre) and progression (prog) tumor samples from ovarian cancer patients (pts) treated with pazopanib (pazo) or placebo (plb).

106. Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium

107. Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

108. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium

109. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

110. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

111. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival:A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

112. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

113. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

114. Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium

115. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.

117. HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer -- a study.

118. Epithelial Ovarian Cancer.

119. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

120. Genome-Wide Association Study for Ovarian Cancer Susceptibility Using Pooled DNA.

121. Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers.

122. Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer

123. Genome-wide significant risk associations for mucinous ovarian carcinoma

124. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

125. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

126. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

127. Additional file 2: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

128. Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

129. Additional file 8: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

130. Additional file 21: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

131. Additional file 11: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

132. Additional file 6: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

133. Additional file 1: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

134. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

135. Additional file 2: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

136. Additional file 9: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

137. Additional file 15: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

138. Additional file 22: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

139. Additional file 10: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

140. Additional file 10: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

141. Additional file 4: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

142. Additional file 6: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

143. Additional file 15: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

144. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

145. Additional file 18: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

146. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

147. Additional file 21: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

148. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

149. Additional file 9: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

150. Additional file 5: of HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

Catalog

Books, media, physical & digital resources